Soc. Generale Knock-Out RHM/ DE000CL5YUV5 /
09/05/2024 13:25:00 | Diferencia-0.100 | Bid13:45:55 | Ask13:45:55 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
49.740EUR | -0.20% | 49.800 Volumen de oferta: 10,000 |
49.830 Tamaño/ Volumen/ Formato de Ask: 10,000 |
RHEINMETALL AG | 37.5277 - | 31/12/2078 | Call |
GlobeNewswire
13:45
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp
13:30
Cosa Resources Announces Summer Exploration Plans for Athabasca Basin Uranium Projects
GlobeNewswire
13:30
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
13:30
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire
13:30
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:30
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:30
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
GlobeNewswire
13:30
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
GlobeNewswire
13:30
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
13:30
Destination XL Group, Inc. to Announce First Quarter 2024 Financial Results on May 30, 2024
GlobeNewswire
13:30
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
13:30
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
GlobeNewswire
13:30
Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2024
GlobeNewswire
13:30
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updat...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página